Lilly provides update on 2024 revenue guidance, announces 2025 …
Jan 14, 2025 · For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 …
Quarterly Results | Eli Lilly and Company
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …
Jan 14, 2025 · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. ... Eli …
Lilly provides update on 2024 revenue guidance, announces 2025 …
Jan 14, 2025 · For Q4 2024, Lilly now expects worldwide revenue to be approximately $13.5 billion, representing growth of 45% compared to Q4 2023. This includes approximately $3.5 …
JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m
Jan 15, 2025 · Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, …
News Release - Eli Lilly and Company
Feb 6, 2024 · New Products(i) revenue grew by $2.19 billion to $2.49 billion in Q4 2023, led by Mounjaro and Zepbound. Growth Products(ii) revenue increased 9% to $5.27 billion in Q4 …
Eli Lilly stock tumbles after new forecasts show weight-loss drug …
Jan 14, 2025 · Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same …
Eli Lilly issues Q4 2024 revenue guidance below consensus
Jan 14, 2025 · Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue …
Eli Lilly issues Q4 2024 revenue guidance below consensus - MSN
Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B, about $400M below the lower end of its recently …
Eli Lilly's Q4 2024 Earnings: What to Expect - Nasdaq
Jan 13, 2025 · Analysts expect Eli Lilly’s EPS to climb 107.9% to $13.14 in fiscal 2024, up from $6.32 in 2023. In fiscal 2025, EPS is projected to increase by 82.9% annually to $24.03.
- Some results have been removed